Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Barbara Depreter

Awards & Distinctions

23 Results

2024

Ultra-deep sequencing and single cell multi-omics characterize measurable residual disease and identify therapy-survived clone in pediatric acute myeloid leukemia

Borhan R.R. SaeedAnastasia SaboliAnna RehammarAdam MolnarErik Delsing MalmbergBarbara DepreterGiti Shah BarkhordarBarbara De MoerlooseTim LammensLars Palmqvist et al.

2022

Deciphering the non-coding landscape of pediatric acute myeloid leukemia

Jolien VanhoorenLaurens Van CampBarbara DepreterMartijn de JongAnne UyttebroeckAn Van DammeLaurence DedekenMarie-Françoise DresseJutte van der Werff ten BoschMattias Hofmans et al.

2021

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara DepreterBarbara De MoerlooseKarl VandepoeleAnne UyttebroeckAn Van DammeEva TerrasBarbara DenysLaurence DedekenMarie-Francoise DresseJutte Van der Werff Ten Bosch et al.

A1 Journal Article in PEDIATRIC RESEARCH

TARP as antigen in cancer immunotherapy

Jolien VanhoorenCharlotte DerpoorterBarbara DepreterLarissa DenewethJan PhilippéBarbara De MoerlooseTim Lammens

A1 Journal Article in CANCER IMMUNOLOGY IMMUNOTHERAPY

2020

Clinical significance of TARP expression in pediatric acute myeloid leukemia

Barbara DepreterBarbara De MoerlooseKarl VandepoeleAnne UyttebroeckAn Van DammeBarbara DenysLaurence DedekenMarie-Françoise DresseJutte Van Der Werff Ten BoschMattias Hofmans et al.

A1 Journal Article in HEMASPHERE

Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia

Barbara DepreterTim LammensJan Philippé

Leukaemic stem cells in AML : where are we now? An update on recent findings and detection

Barbara DepreterBarbara De MoerlooseJan PhilippéTim Lammens

A2 Journal Article in BELGIAN JOURNAL OF HEMATOLOGY

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara DepreterKarin WeeningKarl VandepoeleMagnus EssandBarbara De MoerlooseMaria ThemeliJacqueline CloosDiana HanekampIne MoorsINGE D'HONT et al.

A1 Journal Article in HAEMATOLOGICA

2019

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara DepreterMattias HofmansEva TerrasAnne UyttebroeckAn Van DammeAlina FersterJutte van der Werff ten BoschMarie-Françoise DresseKarl VandepoeleBarbara De Moerloose et al.

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara DepreterMattias HofmansEva TerrasAnne UyttebroeckAn Van DammeAlina FersterJutte Van der Werff Ten BoschMarie-Françoise DresseKarl VandepoeleBarbara De Moerloose et al.

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study

Mattias HofmansBarbara DepreterTim LammensHelene CaveChristian FlothoHenrik HasleValerie de HaasCharlotte M. NiemeyerJan StaryPieter Van Vlierberghe et al.

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara DepreterKarin WeeningKarl VandepoeleM EssandBarbara De MoerlooseM ThemeliJ CloosD HanekampIne MoorsINGE D'HONT et al.

2018

Cancer-related mRNA expression analysis using a novel flow cytometry-based assay

Barbara DepreterJan PhilippéMAGALI MEULBarbara DenysKarl VandepoeleBarbara De MoerlooseTim Lammens

A1 Journal Article in CYTOMETRY PART B-CLINICAL CYTOMETRY

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients

Diana HanekampBarbara DenysGertjan JL KaspersJeroen G te MarveldeGerrit Jan SchuurhuisValerie De HaasBarbara De MoerlooseEveline S de BontC Michel ZwaanAnja de Jong et al.

A1 Journal Article in BRITISH JOURNAL OF HAEMATOLOGY

2017

Dilute Russell's viper venom time reagents in lupus anticoagulant testing : a well-considered choice

Barbara DepreterKatrien Devreese

A1 Journal Article in CLINICAL CHEMISTRY AND LABORATORY MEDICINE

2016

Differences between dilute Russell's viper venom time reagents in lupus anticoagulant testing

Barbara DepreterKatrien Devreese

Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation

Barbara DepreterKatrien Devreese

A1 Journal Article in CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Sampling on ice will not yield reliable uric acid monitoring in rasburicase-treated patients

Barbara DepreterVeronique StoveJoris Delanghe

A1 Journal Article in CLINICAL BIOCHEMISTRY

2015

Bing–Neel syndrome: two unexpected cases and a review of the literature

Margot G Van CauwenbergeBarbara DepreterEls DumoulinJan EmmerechtsFriedel NolletLuc Vanopdenbosch

A1 Journal Article in JOURNAL OF THE NEUROLOGICAL SCIENCES

Clotting time or Rosner index for mixing test interpretation makes a difference in the overal lupus anticoagulant test result

Barbara DepreterKatrien Devreese

2014

Biclonal biphenotypical B-cell lymphocytosis: a CLL in disguise?

Barbara DepreterEls DumoulinJohan BillietBarbara CauwelierBirgit MaesCharlotte MatthysJan Van DroogenbroeckFriedel NolletJan Emmerechts

A2 Journal Article in BELGIAN JOURNAL OF HEMATOLOGY

Uw diagnose? : Sebastian Syndrome

Barbara DepreterEls DumoulinDominik SelleslagJan EmmerechtsJohan Billiet

Editorial material

2013

Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysis patients

Barbara DepreterAnnemieke C HeijboerMichel Langlois

A1 Journal Article in CLINICA CHIMICA ACTA